Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-Health Disparities Subcommittee (HDS), 46281 [2015-19040]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 149 / Tuesday, August 4, 2015 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—Health Disparities
Subcommittee (HDS)
Notice of Cancellation: This notice
was published in the Federal Register
on July 20, 2015, Volume 80, Number
138, page 42820. The meeting
previously scheduled to convene on
August 11, 2015 has been cancelled.
Contact Person for more Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600
Clifton Road NE., M/S K–77, Atlanta,
GA 30333; telephone (770) 488–8200,
Email: LEL1@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–19040 Filed 8–3–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
tkelley on DSK3SPTVN1PROD with NOTICES
Request for Nominations of
Candidates To Serve on the Breast and
Cervical Cancer Early Detection and
Control Advisory Committee
(BCCEDCAC)
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for membership on The
Breast and Cervical Cancer Early
Detection and Control Advisory
Committee. The committee provides
advice and guidance to the Secretary,
HHS, and the Director, CDC, regarding
the early detection and control of breast
and cervical cancer. The committee
makes recommendations regarding
national program goals and objectives;
implementation strategies; program
priorities, including surveillance,
epidemiologic investigations, education
and training, information dissemination,
VerDate Sep<11>2014
18:45 Aug 03, 2015
Jkt 235001
professional interactions and
collaborations, and policy.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. The Secretary, HHS, acting
through the Director, CDC, shall appoint
to the advisory committee nominees
with expertise in breast cancer, cervical
cancer, medicine, public health,
behavioral science, epidemiology,
radiology, pathology, clinical medical
care, health education, and surveillance.
Two members may be representatives of
the general public with personal
experience in issues related to breast or
cervical cancer early detection and
control. Members may be invited to
serve for up to four years.
The next cycle of selection of
candidates will conclude in the Fall of
2015, for selection of potential
nominees to replace members whose
terms will end on March 31, 2016.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of BCCEDCAC
objectives (https://www.cdc.gov/maso/
FACM/facmBCCEDCAC.htm). The U.S.
Department of Health and Human
Services will give close attention to
equitable geographic distribution and to
minority and female representation so
long as the effectiveness of the
Committee is not impaired.
Appointments shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
HIV status, disability, and cultural,
religious, or socioeconomic status.
Consideration is given to a broad
representation of geographic areas
within the U.S., with diverse
representation of both genders, all
ethnic and racial groups, and persons
with disabilities. Nominees must be
U.S. citizens, and cannot be full-time
employees of the U.S. Government.
Candidates should submit the
following items:
D Current curriculum vitae or resume,
including complete contact information
(name, affiliation, mailing address,
telephone numbers, fax number, email
address)
D A 150 word biography for the
nominee;
D At least one letter of
recommendation from a person(s) not
employed by the U.S. Department of
Health and Human Services. Candidates
may submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by HHS.
Nominations should be submitted
((postmarked or received)) by September
25, 2015.
PO 00000
Frm 00048
Fmt 4703
Sfmt 9990
46281
• Electronic submissions: You may
submit nominations, including
attachments, electronically to
bccedcac@cdc.gov.
• Regular, Express or Overnight Mail:
Written nominations may be submitted
to the following addressee only: Ms.
Jameka Reese Blackmon, M.B.A.,
C.M.P., c/o BCCEDCAC Secretariat,
Centers for Disease Control and
Prevention, 3719 North Peachtree Road,
Bldg. 100 Chamblee, GA 30341.
Telephone and facsimile submissions
cannot be accepted.
Nominations may be submitted by the
candidate or by the person/organization
recommending the candidate.
Candidates invited to serve will be
asked to submit the ‘‘Executive Branch
Confidential Financial Disclosure
Report, OGE 450’’ for Special
Government Employees Serving on
Federal Advisory Committees at the
Centers for Disease Control and
Prevention. This form allows CDC to
determine whether there is a conflict of
interest between that person’s public
responsibilities as a Special Government
Employee and private interests and
activities, or the appearance of a lack of
impartiality, as defined by Federal
regulation. The form may be viewed and
downloaded at https://www.usoge.gov/
forms/oge450_pdf/oge450_
accessible.pdf. This form should not be
submitted as part of the nomination.
Contact Person for More Information:
Jameka R. Blackmon, MBA, CMP,
Designated Federal Officer, National
Center for Chronic Disease Prevention
and Health Promotion, CDC, 4770
Buford Hwy., NE., Mailstop F76,
Atlanta, Georgia, 30341, Telephone
(770) 488–4880; Fax (770) 488–4760;
Email: bccedcac@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and the
Agency for Toxic Substances and
Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–19041 Filed 8–3–15; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\04AUN1.SGM
04AUN1
]]>Agencies
[Federal Register Volume 80, Number 149 (Tuesday, August 4, 2015)]
[Notices]
[Page 46281]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-19040]
[[Page 46281]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention--Health Disparities Subcommittee (HDS)
Notice of Cancellation: This notice was published in the Federal
Register on July 20, 2015, Volume 80, Number 138, page 42820. The
meeting previously scheduled to convene on August 11, 2015 has been
cancelled.
Contact Person for more Information: Leandris Liburd, Ph.D.,
M.P.H., M.A., Designated Federal Officer, Health Disparities
Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton
Road NE., M/S K-77, Atlanta, GA 30333; telephone (770) 488-8200, Email:
LEL1@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2015-19040 Filed 8-3-15; 8:45 am]
BILLING CODE 4163-18-P
